| Previous close | 54.28 |
| Open | 54.28 |
| Bid | 50.35 |
| Ask | 51.40 |
| Strike | 145.00 |
| Expiry date | 2025-03-21 |
| Day's range | 54.28 - 54.28 |
| Contract range | N/A |
| Volume | |
| Open interest | 10 |
ZacksPharma Stock Roundup: FDA Approves SNY's Dupixent for COPD & More
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
ZacksAbbVie Cuts 2024 Earnings Guidance to Include Acquisition Costs
ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
PR NewswireAllergan Aesthetics and Girls Inc. Celebrate Six Years and Challenge You to Take the Pledge to Support Mentorship in STEM
Today Allergan Aesthetics, an AbbVie company, announces the sixth consecutive year of partnership with Girls Inc. The partnership supports high school and college girls' interest in STEM and mentorship.
© 2024 Yahoo. All rights reserved.